صيدلية اونلاين

DAKLINZA TAB 60 MG ( 28 )

$43,534.20 $11,766.00

Daklinza

daclatasvir

Therapeutic indications
hepatitis C infection, chronic

Daklinza is indicated in combination with other medicinal products for the treatment of chronic hepatitis C virus (HCV) infection in adults

For HCV genotype specific activity,

Adult Dosing .

Dosage forms:  30,60


hepatitis C infection, chronic

[genotype 1]

Dose: 60 mg PO qd x12wk; Info: screen for NS5A polymorphism in pts w/ genotype 1a; give w/ sofosbuvir; D/C tx if sofosbuvir D/C

[genotype 3]

Dose: 60 mg PO qd x12wk; Info: give w/ sofosbuvir; D/C tx if sofosbuvir D/C

renal dosing

[no adjustment]

hepatic dosing

[no adjustment]

Peds Dosing .

Peds dosing is currently unavailable or not applicable for this drug.


Contraindications / Cautions .

hypersens. to drug/class/compon.

Drug Interactions .

Overview

daclatasvir

Interaction Characteristics:

CYP3A4 substrate

BCRP inhibitor

OATP1B1 inhibitor, weak

OATP1B3 inhibitor, weak

P-gp inhibitor, weak

Reviews